Critical review of the safety assessment of nano-structured silica additives in food.
The development of nano-materials is viewed as one of the most important technological advances of the 21st century and new applications of nano-sized particles in the production, processing, packaging or storage of food are expected to emerge soon. This trend of growing commercialization of engineered nano-particles as part of modern diet will substantially increase oral exposure. Contrary to the proven benefits of nano-materials, however, possible adverse health effects have generally received less attention. This problem is very well illustrated by nano-structured synthetic amorphous silica (SAS), which is a common food additive since several decades although the relevant risk assessment has never been satisfactorily completed. A no observed adverse effect level of 2500 mg SAS particles/kg body weight per day was derived from the only available long-term administration study in rodents. However, extrapolation to a safe daily intake for humans is problematic due to limitations of this chronic animal study and knowledge gaps as to possible local intestinal effects of SAS particles, primarily on the gut-associated lymphoid system. This uncertainty is aggravated by digestion experiments indicating that dietary SAS particles preserve their nano-sized structure when reaching the intestinal lumen. An important aspect is whether food-borne particles like SAS alter the function of dendritic cells that, embedded in the intestinal mucosa, act as first-line sentinels of foreign materials. We conclude that nano-particles do not represent a completely new threat and that most potential risks can be assessed following procedures established for conventional chemical hazards. However, specific properties of food-borne nano-particles should be further examined and, for that purpose, in vitro tests with decision-making cells of the immune system are needed to complement existing in vivo studies.
Institute of Pharmacology and Toxicology, University of Zurich-Vetsuisse, Winterthurerstrasse 260, 8057, Zurich, Switzerland.
Hans Christian
HC
Winkler
Immunology Division, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057, Zurich, Switzerland.
Mark
M
Suter
Institute of Pharmacology and Toxicology, University of Zurich-Vetsuisse, Winterthurerstrasse 260, 8057, Zurich, Switzerland. naegelih@vetpharm.uzh.ch.
Hanspeter
H
Naegeli
D000818:Animals; D005503:Food Additives / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry; D005504:Food Analysis; D041981:Gastrointestinal Tract / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D006801:Humans; D049329:Nanostructures / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry; D018570:Risk Assessment; D012822:Silicon Dioxide / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry
D005503:Food Additives; D012822:Silicon Dioxide
Aerosil; Corona; Dendritic cells; E 551; Food toxicology; Lymphoid tissue; Nanomaterial; SAS; Silicium dioxide; Synthetic amorphous silica